Corcept Therapeutics (CORT) Return on Capital Employed [ROCE] (2011 - 2026)
Corcept Therapeutics (CORT) posted Return on Capital Employed [ROCE] of 0.92% for Q2 2026, down 14.09 percentage points from 15.01% a year earlier but up 2.13 percentage points from the prior quarter.
Powered by 
Analysis
Corcept Therapeutics (CORT) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends
For FY2025, Corcept Therapeutics' Return on Capital Employed [ROCE] came in at 6.66%, down 16.54 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] shows a five-year change of -22.18 percentage points (FY2020 to FY2025).
- In prior years, Corcept Therapeutics' Return on Capital Employed [ROCE] was 23.20% in FY2024 (+1.66 pp), 21.54% in FY2023 (-4.58 pp), 26.13% in FY2022 (-1.52 pp) and 27.65% in FY2021 (-1.19 pp).
- Quarterly Return on Capital Employed [ROCE] has run from a low of -1.21% in Q1 2026 to a high of 33.86% in Q1 2022 over five years.
- On a year-over-year basis, Return on Capital Employed [ROCE] has declined in each of the last seven quarters, with an average year-over-year change of -8.93 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q1 2022, with a gain of 12.74 percentage points; the weakest was Q1 2026, with a drop of 17.04 percentage points.
- According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -1.21% (Q1 2026), 6.75% (Q4 2025) and 10.24% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 11.86% |
| 10 | Corcept Therapeutics | 12.33 Bn | 10.89 Bn | 252.09 Mn | 0.92% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.92% |
| Mar 31, 2026 | -1.21% |
| Dec 31, 2025 | 6.75% |
| Sep 30, 2025 | 10.24% |
| Jun 30, 2025 | 15.01% |
| Mar 31, 2025 | 15.83% |
| Dec 31, 2024 | 20.39% |
| Sep 30, 2024 | 23.00% |
| Jun 30, 2024 | 21.89% |
| Mar 31, 2024 | 22.52% |
| Dec 31, 2023 | 21.32% |
| Sep 30, 2023 | 22.43% |
| Jun 30, 2023 | 20.68% |
| Mar 31, 2023 | 19.30% |
| Dec 31, 2022 | 23.18% |
| Sep 30, 2022 | 27.46% |
| Jun 30, 2022 | 30.26% |
| Mar 31, 2022 | 33.86% |
| Dec 31, 2021 | 27.24% |
| Sep 30, 2021 | 22.23% |
API Access
Corcept Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CORT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "CORT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CORT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();